We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$135M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$54.5M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$24.8M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$13.3M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$11.5M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$60M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$30.3M
3
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$20.3M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$17.2M
5
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTBA icon
2626
West Bancorporation
WTBA
$482M
$24K ﹤0.01%
964
+760
+373% +$17.2K
ZTO icon
2627
ZTO Express
ZTO
$18.2B
$24K ﹤0.01%
+1,705
New +$24.6K
PVLA
2628
Palvella Therapeutics
PVLA
$2.2B
$24K ﹤0.01%
+52
New +$22.2K
ERF
2629
DELISTED
Enerplus Corporation
ERF
$24K ﹤0.01%
1,891
+1,154
+157% +$10.3K
DSKE
2630
DELISTED
Daseke, Inc. Common Stock
DSKE
$24K ﹤0.01%
+1,838
New +$22.9K
MYOK
2631
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$24K ﹤0.01%
554
+454
+454% +$14.5K
AFH
2632
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$24K ﹤0.01%
1,291
+244
+23% +$3.95K
LLL
2633
DELISTED
L3 Technologies, Inc.
LLL
$24K ﹤0.01%
128
+96
+300% +$17.2K
NRCIB
2634
DELISTED
National Research Corp Class B
NRCIB
$24K ﹤0.01%
+442
New +$23.2K
OMED
2635
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$24K ﹤0.01%
5,250
-6,240
-54% -$25.3K
ALDX icon
2636
Aldeyra Therapeutics
ALDX
$93.5M
$23K ﹤0.01%
3,183
+3,171
+26,425% +$16.6K
CNTY icon
2637
Century Casinos
CNTY
$32.9M
$23K ﹤0.01%
2,772
+1,039
+60% +$7.45K
VISN
2638
Vistance Networks Inc
VISN
$2.32B
$23K ﹤0.01%
+705
New +$24.1K
CXW icon
2639
CoreCivic
CXW
$3.17B
$23K ﹤0.01%
+850
New +$22.6K
DG icon
2640
Dollar General
DG
$28.1B
$23K ﹤0.01%
287
-9
-3% -$674
EQNR icon
2641
Equinor
EQNR
$93.4B
$23K ﹤0.01%
1,148
-13,502
-92% -$249K
FRT icon
2642
Federal Realty Investment Trust
FRT
$10.4B
$23K ﹤0.01%
183
+18
+11% +$2.31K
GGB icon
2643
Gerdau
GGB
$10B
$23K ﹤0.01%
8,403
-54,196
-87% -$152K
HQH
2644
abrdn Healthcare Investors
HQH
$1.31B
$23K ﹤0.01%
931
-3,524
-79% -$88.5K
MNOV icon
2645
MediciNova
MNOV
$66.4M
$23K ﹤0.01%
+3,664
New +$19.5K
NXRT
2646
NexPoint Residential Trust
NXRT
$638M
$23K ﹤0.01%
+961
New +$23.1K
OKE icon
2647
Oneok
OKE
$54.8B
$23K ﹤0.01%
413
-979
-70% -$52.9K
ORN icon
2648
Orion Group Holdings
ORN
$412M
$23K ﹤0.01%
+3,613
New +$22.9K
PSEC icon
2649
Prospect Capital
PSEC
$1.11B
$23K ﹤0.01%
+3,483
New +$26.1K
RACE icon
2650
Ferrari
RACE
$71.8B
$23K ﹤0.01%
208
-56
-21% -$5.97K
104 105
106
107 108

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.